Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
OMIM | RCV000032691 | SCV000056454 | pathogenic | Neuronopathy, distal hereditary motor, type 7A | 2012-12-07 | no assertion criteria provided | literature only | |
Inherited Neuropathy Consortium | RCV000790226 | SCV000929618 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only | ||
Prevention |
RCV003894840 | SCV004712964 | likely pathogenic | SLC5A7-related disorder | 2023-11-06 | no assertion criteria provided | clinical testing | The SLC5A7 c.1497delG variant is predicted to result in a frameshift and premature protein termination (p.Lys499Asnfs*13). This variant was reported to segregate with several affected individuals in a large family with hereditary motor neuropathy, type VII (Barwick et al 2012. PubMed ID: 23141292). This variant occurs in the last exon of the SLC5A7 gene and likely escapes nonsense-mediated decay and functional studies indicate a dominant-negative impact (Barwick et al 2012. PubMed ID: 23141292). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Other frameshift variants in the last exon of SLC5A7 have been reported to be pathogenic for autosomal dominant hereditary motor neuropathy (Salter et al. 2018. PubMed ID: 29582019). This variant is interpreted as likely pathogenic. |